Limiting e-cigarettes sales should be reasonable: Russian official

Aug.01.2022
Limiting e-cigarettes sales should be reasonable: Russian official
Russian official supports reasonable restrictions on e-cigarettes and hopes to reduce smoking rates in the country.

Alexei Kurinny, the Deputy Chairman of the Health Protection Committee in the State Duma, has stated that measures to restrict the use and sale of electronic cigarettes should be seen as reasonable rather than impossible. In an interview with Lenta.ru, he commented on the Health Ministry's push for greater regulation of these products.


Earlier, the Ministry of Health advocated for a ban on electronic cigarettes. Marine Gambaryan, director of the National Treatment and Prevention Research Center and the Tobacco Consumption Prevention and Control Center at the Ministry of Health, emphasized that it is impossible to achieve the national goal of combating tobacco consumption unless sales of electronic cigarettes are restricted.


The representative said, "I want to comprehend specifically what the restrictions entail and their intended plan of action, because I support measures to decrease the supply of various smoking blends, e-cigarettes, and classic cigarettes. However, the issue is that these measures should be reasonable.


He believes that it is necessary for Russia to implement an anti-smoking strategy, whereby the number of smokers over the next 20 years should gradually and accurately decrease to 5% of the population.


Here, we can also discuss the creation of special stores that are separate from everything else, raising the age limit for purchasing cigarettes and smoking mixtures. Perhaps there are also other issues related to flavor additives, such as in European Union countries where flavor additives have already been banned. We have yet to fully address this problem, with some things being prohibited and others not, according to Kurinny.


Earlier, Vladislav Zaslavsky, the Deputy Director of the Digital Tagging System and Product Legalization Department at the Ministry of Industry and Trade, publicly opposed the ban on electronic cigarettes. He stated that the ban would lead to the formation of a black market, making e-cigarettes uncontrollable. It is currently unclear what nicotine products will appear on the black market and how much of them there will be. Zaslavsky urged the swift implementation of a mandatory tagging system.


I'm sorry, as an AI language model, I only translate sentences. Please provide me with the sentence that needs to be translated.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI said on its latest earnings call that Japan’s tax cycle will weigh on 2026 performance, while smoke-free growth is expected to re-accelerate thereafter. The discussion also covered U.S. regulation, ZYN strategy and AI-driven efficiency.
Feb.07
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
BAT says a U.S. import block on some disposable vapes could cut illegal sales by about a third
BAT says a U.S. import block on some disposable vapes could cut illegal sales by about a third
Reuters reported that British American Tobacco (BAT) CEO Tadeu Marroco said a potential U.S. move to block imports of some disposable vapes could reduce the market for unregulated e-cigarettes by as much as a third, though any impact is unlikely before 2027.
Feb.13 by 2FIRSTS.ai
Shanghai releases 2025 smoke-free white paper: smoking incidence at designated smoke-free venues falls to 12.6%
Shanghai releases 2025 smoke-free white paper: smoking incidence at designated smoke-free venues falls to 12.6%
Shanghai released its 2025 White Paper on Smoking Control in Public Places at a city tobacco control meeting on March 5. The paper reports a 12.6% smoking incidence in legally designated smoke-free venues, down 0.4 percentage points from 2024, and says 98.2% of residents support a full indoor smoking ban.
Mar.05
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Concerns about the effects of vaping on young people and public health were raised at County Hall, the report said, with Cllr Chris Jarman saying it may one day be viewed as “akin to asbestos.” Jarman cited NHS-related research and a case highlighted by Hull University Teaching Hospitals NHS Trust: a 15-year-old admitted with chest pain and breathing difficulty who reported cannabis use and vaping about 500 puffs per day and was diagnosed via CT with “air leak syndrome.”
Feb.27 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11